A novel cyclic peptide (Naturido) modulates glia-neuron interactions in vitro and reverses ageing-related deficits in senescence-accelerated mice

PLoS One. 2021 Jan 27;16(1):e0245235. doi: 10.1371/journal.pone.0245235. eCollection 2021.

Abstract

The use of agents that target both glia and neurons may represent a new strategy for the treatment of ageing disorders. Here, we confirmed the presence of the novel cyclic peptide Naturido that originates from a medicinal fungus (Isaria japonica) grown on domestic silkworm (Bombyx mori). We found that Naturido significantly enhanced astrocyte proliferation and activated the single copy gene encoding the neuropeptide VGF and the neuron-derived NGF gene. The addition of the peptide to the culture medium of primary hippocampal neurons increased dendrite length, dendrite number and axon length. Furthermore, the addition of the peptide to primary microglial cultures shifted CGA-activated microglia towards anti-inflammatory and neuroprotective phenotypes. These findings of in vitro glia-neuron interactions led us to evaluate the effects of oral administration of the peptide on brain function and hair ageing in senescence-accelerated mice (SAMP8). In vivo analyses revealed that spatial learning ability and hair quality were improved in Naturido-treated mice compared with untreated mice, to the same level observed in the normal ageing control (SAMR1). These data suggest that Naturido may be a promising glia-neuron modulator for the treatment of not only senescence, but also Alzheimer's disease and other neurodegenerative diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / chemistry
  • Acetylcholinesterase / metabolism
  • Aging / drug effects*
  • Animals
  • Astrocytes / cytology
  • Astrocytes / metabolism
  • Axons / drug effects
  • Axons / physiology
  • Cell Proliferation / drug effects
  • Dendrites / drug effects
  • Dendrites / physiology
  • Female
  • Humans
  • Hypocreales / metabolism
  • Male
  • Maze Learning / drug effects
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred ICR
  • Microglia / cytology
  • Microglia / drug effects*
  • Microglia / metabolism
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Peptides, Cyclic / administration & dosage
  • Peptides, Cyclic / chemistry
  • Peptides, Cyclic / isolation & purification
  • Peptides, Cyclic / pharmacology*
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism
  • Up-Regulation / drug effects

Substances

  • Peptides, Cyclic
  • Transforming Growth Factor beta
  • Acetylcholinesterase

Supplementary concepts

  • Isaria japonica

Grants and funding

This study was supported by a grant from the Japan Society for the Promotion of Science to KS. DKS Co., Ltd. (the parent company of Biococoon Laboratories, Inc.) provided support for this study in the form of salaries for KS, SI, MK, ME, PS, HI and NE. The specific roles of these authors are articulated in the ‘author contributions’ section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.